In the news

Explore the latest Leaps investments, news on our companies, thought leadership, and press resources.

In the news

Leaps events

Spotlight on Juergen Eckhardt

Juergen Eckhardt is EVP and Head of Leaps by Bayer, the impact investment arm, and Head of Business Development, & Licensing (BD&L) for the Pharmaceuticals division. He is a medical doctor and venture investor in healthcare, biotech, and agriculture with more than 20 years of experience. He is a strong believer that scientific breakthroughs can help us overcome some of humanity’s biggest challenges, including to cure and prevent chronic disease and to feed an ever-growing world population in a sustainable way – in short: science for a better life. He holds an MD from the University of Basel, Switzerland, and an MBA from INSEAD in Fontainebleau, France.

Read More

Press Kit

Leaps by Bayer is the impact investment arm of Bayer AG. We invest in teams pursuing fundamental breakthroughs in life science, targeting 10 huge challenges facing humanity.

Some call them impossible. We call them “Leaps”.

Media Contact

Kira Peikoff

Kira Peikoff is a former journalist who covered emerging biotechnologies for publications including The New York Times, Newsweek, and Popular Mechanics. She now leads communications for Leaps by Bayer.

Our return
to humanity

The Leaps team brings together a diverse group of individuals with expertise in biotech, healthcare, agriculture, investment, and communication.